Laikai Pharmaceutical-B (02105) issued an announcement. The board of directors of the company has resolved to approve the recommendation to adopt a share award plan, subject to shareholders' approval at the annual shareholders' meeting.
According to the announcement, the purpose of the share award program is to attract and retain participants who have contributed significantly to the long-term growth and success of the Group, recognize and reward their past contributions to the Group, provide participants with an opportunity to obtain the company's exclusive rights and encourage participants to make further contributions to the company, and strive to enhance the value of the company and its shares in order to meet the overall interests of the company and its shareholders.